Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimens
Pedraz-Valdunciel, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Giannoukakos, Stavros (Universidad de Granada)
Potie, Nicolas (Universidad de Granada)
Giménez-Capitán, Ana (Pangaea Oncology)
Huang, Chung-Ying (NanoString Technologies)
Hackenberg, Michael (Universidad de Granada)
Fernandez-Hilario, Alberto (Universidad de Granada)
Bracht, Jillian (Pangaea Oncology)
Filipska, Martyna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Aldeguer, Erika (Pangaea Oncology)
Rodríguez, Sonia (Pangaea Oncology)
Bivona, Trever (University of California San Francisco)
Warren, Sarah (NanoString Technologies)
Aguado, Cristina (Pangaea Oncology)
Ito, Masaoki (Hiroshima University)
Aguilar-Hernández, Andrés (Quirón-Dexeus University Institute)
Molina-Vila, Miguel Ángel (Pangaea Oncology)
Rosell, Rafael (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Universitat Autònoma de Barcelona

Data:	2022
Resum:	Although many studies highlight the implication of circular RNAs (circRNAs) in carcinogenesis and tumor progression, their potential as cancer biomarkers has not yet been fully explored in the clinic due to the limitations of current quantification methods. Here, we report the use of the nCounter platform as a valid technology for the analysis of circRNA expression patterns in non-small cell lung cancer (NSCLC) specimens. Under this context, our custom-made circRNA panel was able to detect circRNA expression both in NSCLC cells and formalin-fixed paraffin-embedded (FFPE) tissues. CircFUT8 was overexpressed in NSCLC, contrasting with circEPB41L2, circBNC2, and circSOX13 downregulation even at the early stages of the disease. Machine learning (ML) approaches from different paradigms allowed discrimination of NSCLC from nontumor controls (NTCs) with an 8-circRNA signature. An additional 4-circRNA signature was able to classify early-stage NSCLC samples from NTC, reaching a maximum area under the ROC curve (AUC) of 0. 981. Our results not only present two circRNA signatures with diagnosis potential but also introduce nCounter processing following ML as a feasible protocol for the study and development of circRNA signatures for NSCLC. Aberrant circular RNA (circRNA) expression is present in lung cancer. Using nCounter with machine learning, we discovered two signatures able to discriminate FFPE lung cancer samples from controls even at early stage. Our results not only highlight the potential of circRNAs as lung cancer biomarkers but also introduce nCounter as a suitable platform for circRNA expression studies in these samples.
Ajuts:	European Commission 765492
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Biomarkers ; Cancer ; Circrna ; Diagnosis ; Ncounter ; NSCLC
Publicat a:	Molecular oncology, Vol. 16 (february 2022) , p. 2367-2383, ISSN 1878-0261

DOI: 10.1002/1878-0261.13182
PMID: 35060299

17 p, 2.1 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Articles > Articles de recerca
Articles > Articles publicats